Website Overview: promontorytx.comopen_in_new

General information

Last Updated: 2024-06-20 (yyyy-mm-dd).

Title: Promontory Therapeutics Advancing small molecule immunotherapy

Description: Promontory Therapeutics is developing novel small molecule immunogenic anti cancer agents Their lead agent PT 112 is a highly potent immunogenic cell death ICD inducer currently in Phase 2 clinical development

Language: English

Contact information

Email

• info [at]promontorytx.com

Social Links

• Linkedin open_in_new: https://linkedin.com/company/phosplatin-therapeutics/

• X open_in_new: https://twitter.com/PromontoryTx

Services and technology that the website used

Vendor

• Email Vendor: google.com